Mirae Asset Global ETFs Holdings’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$884K Buy
60,615
+97
+0.2% +$936 ﹤0.01% 1698
2026
Q1
$449K Buy
60,518
+608
+1% +$6.4K ﹤0.01% 1937
2025
Q4
$705K Sell
59,910
-24
-0% -$259 ﹤0.01% 1715
2025
Q3
$463K Sell
59,934
-10,757
-15% -$75.3K ﹤0.01% 1901
2025
Q2
$517K Sell
70,691
-5,107
-7% -$41.2K ﹤0.01% 1804
2025
Q1
$719K Buy
75,798
+3,254
+4% +$40.6K ﹤0.01% 1659
2024
Q4
$1.2M Buy
72,544
+2,724
+4% +$42.3K ﹤0.01% 1460
2024
Q3
$1.03M Buy
69,820
+4,740
+7% +$74.2K ﹤0.01% 1525
2024
Q2
$903K Buy
+65,080
New +$923K ﹤0.01% 1509

Other funds holding NEO

Mirae Asset Global ETFs Holdings's NEO Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its NeoGenomics (NEO) stake by 0.16% in Q2 2026, buying an estimated $936 and bringing the position to 60,615 shares worth $884K. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Mirae Asset Global ETFs Holdings first reported a position in NEO in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.2M in Q4 2024. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 60,615 shares of NeoGenomics worth $884K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 97 NeoGenomics shares in Q2 2026, an estimated $936.
  • NeoGenomics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1698 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in NeoGenomics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's NeoGenomics position peaked at $1.2M in Q4 2024.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.